Hydroxychloroquine Dose and Hospitalizations for Active Lupus.
Jacquelyn NestorHyon ChoiChristian ManciniBaijun ZhouYuqing ZhangKaren H CostenbaderApril M JorgePublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
The use of lower doses of HCQ was associated with an increased risk of hospitalizations for active SLE. Although the long-term risk of HCQ retinopathy must be acknowledged, this must be balanced with the short-term and cumulative risks of increased SLE activity.